In conclusion, our study indicated a key role of OC and immune cell crosstalk in the pathophysiology of bone disease in MM and highlights the possibility of targeting LIGHT to preserve bone health in MM patients. This evidence concerns the gene TNFSF14 and Miyoshi myopathy.